%0 Generic
%A Tabernero, J.
%A Bekaii-Saab, T.
%A Aguilera, M. Safont
%A Cubillo, A.
%A Garcia-Carbonero, R.
%A Limon, L.
%A Rodriguez-Salas, N.
%A Tournigand, C.
%A Borg, C.
%A Raghav, K.
%A Finley, G.
%A Strickler, J.
%A Beier, F.
%A Salim, S.
%A Esser, R.
%A Liu, E.
%A Adrian, S.
%A Lopez-Lopez, C.
%T PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/27224
%~